Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between Ganga Pharmaceuticals IPO and KP Energy IPO.
Ganga Pharmaceuticals IPO is a SME Book Built Issue IPO proposed to list at BSE SME while KP Energy IPO is a SME Book Built Issue proposed to list at BSE SME.
| Ganga Pharmaceuticals IPO | KP Energy IPO | |
|---|---|---|
| Logo |  |
 |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price Issue | Book Built Issue |
| Listing At | BSE SME | BSE SME |
| Lead Managers | First Overseas Capital Limited | Aryaman Financial Services Limited |
| Registrar | Kfin Technologies Limited | Bigshare Services Pvt Ltd |
| Market Maker | ||
| DRHP | DRHP  |
DRHP |
| RHP | RHP |
RHP |
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of Ganga Pharmaceuticals IPO is up to ₹1.54 Cr whereas the issue size of the KP Energy IPO is up to ₹6.44 Cr. The final issue price of Ganga Pharmaceuticals IPO is ₹15.00 per share and of KP Energy IPO is ₹70.00 per share.
| Ganga Pharmaceuticals IPO | KP Energy IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹60.00 per share | |
| Issue Price (Upper) | ₹70.00 per share | |
| Issue Price (Final) | ₹15.00 per share | ₹70.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 8000 shares | 2000 shares |
| Fresh Issue Size | ||
| Fresh Issue Size (Amount) | ||
| OFS Issue Size | ||
| OFS Issue Size (Amount) | ||
| Issue Size Total | 10,24,000 shares | 9,20,000 shares |
| Issue Size Total (Amount) | up to ₹1.54 Cr | up to ₹6.44 Cr |
Ganga Pharmaceuticals IPO opens on Jan 29, 2016, while KP Energy IPO opens on Feb 15, 2016. The closing date of Ganga Pharmaceuticals IPO and KP Energy IPO is Feb 09, 2016, and Feb 17, 2016, respectively.
| Ganga Pharmaceuticals IPO | KP Energy IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jan 29, 2016 | Feb 15, 2016 |
| Issue Close | Feb 09, 2016 | Feb 17, 2016 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | ||
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Ganga Pharmaceuticals IPO P/E ratio is , as compared to KP Energy IPO P/E ratio of .
| Ganga Pharmaceuticals IPO | KP Energy IPO | |
|---|---|---|
| Financial | ||
| Promoter Shareholding (Pre-Issue) | 91.05% | |
| Promoter Shareholding (Post-Issue) | 68.09% | |
| P/E Ratio | ||
| Market Cap | ||
| ROE | ||
| ROCE | ||
| Debt/Equity | ||
| EPS | ||
| RoNW | 1.27%% |
In the Ganga Pharmaceuticals IPO retail investors (RII) are offered while in KP Energy IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Ganga Pharmaceuticals IPO and in KP Energy IPO.
| Ganga Pharmaceuticals IPO | KP Energy IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | 56,000 shares | |
| QIB | ||
| NII | ||
| RII | ||
| Employee | ||
| Others | ||
| Total |
Ganga Pharmaceuticals IPO subscribed in total, whereas KP Energy IPO subscribed .
| Ganga Pharmaceuticals IPO | KP Energy IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | ||
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | ||
| Employee (times) | ||
| Other (times) | ||
| Total (times) |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
